These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

171 related items for PubMed ID: 2435339

  • 41. Gender and haplotype effects upon hematological manifestations of adult sickle cell anemia.
    Steinberg MH, Hsu H, Nagel RL, Milner PF, Adams JG, Benjamin L, Fryd S, Gillette P, Gilman J, Josifovska O.
    Am J Hematol; 1995 Mar; 48(3):175-81. PubMed ID: 7532353
    [Abstract] [Full Text] [Related]

  • 42. Fetal hemoglobin in sickle cell anemia: relation to regulatory sequences cis to the beta-globin gene. Multicenter Study of Hydroxyurea.
    Lu ZH, Steinberg MH.
    Blood; 1996 Feb 15; 87(4):1604-11. PubMed ID: 8608254
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44. HbF production in beta thalassaemia heterozygotes for the IVS-II-1 G-->A beta(0)-globin mutation. Implication of the haplotype and the (G)gamma-158 C-->T mutation on the HbF level.
    Dedoussis GV, Mandilara GD, Boussiu M, Loutradis A.
    Am J Hematol; 2000 Jul 15; 64(3):151-5. PubMed ID: 10861808
    [Abstract] [Full Text] [Related]

  • 45. Original Research: A case-control genome-wide association study identifies genetic modifiers of fetal hemoglobin in sickle cell disease.
    Liu L, Pertsemlidis A, Ding LH, Story MD, Steinberg MH, Sebastiani P, Hoppe C, Ballas SK, Pace BS.
    Exp Biol Med (Maywood); 2016 Apr 15; 241(7):706-18. PubMed ID: 27022141
    [Abstract] [Full Text] [Related]

  • 46. Treatment of sickle cell anemia with 5-azacytidine results in increased fetal hemoglobin production and is associated with nonrandom hypomethylation of DNA around the gamma-delta-beta-globin gene complex.
    Charache S, Dover G, Smith K, Talbot CC, Moyer M, Boyer S.
    Proc Natl Acad Sci U S A; 1983 Aug 15; 80(15):4842-6. PubMed ID: 6192443
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Hydroxyurea in sickle cell disease--a study of clinico-pharmacological efficacy in the Indian haplotype.
    Italia K, Jain D, Gattani S, Jijina F, Nadkarni A, Sawant P, Nair S, Mohanty D, Ghosh K, Colah R.
    Blood Cells Mol Dis; 2009 Aug 15; 42(1):25-31. PubMed ID: 18954999
    [Abstract] [Full Text] [Related]

  • 50. The -158 site 5' to the G gamma gene and G gamma expression.
    Labie D, Dunda-Belkhodja O, Rouabhi F, Pagnier J, Ragusa A, Nagel RL.
    Blood; 1985 Dec 15; 66(6):1463-5. PubMed ID: 4063531
    [Abstract] [Full Text] [Related]

  • 51. Effect of alpha-thalassemia on sickle-cell anemia linked to the Arab-Indian haplotype in India.
    Mukherjee MB, Lu CY, Ducrocq R, Gangakhedkar RR, Colah RB, Kadam MD, Mohanty D, Nagel RL, Krishnamoorthy R.
    Am J Hematol; 1997 Jun 15; 55(2):104-9. PubMed ID: 9209006
    [Abstract] [Full Text] [Related]

  • 52. Beta-globin gene cluster haplotypes linked to the betaS gene in western India.
    Mukherjee MB, Surve RR, Gangakhedkar RR, Ghosh K, Colah RB, Mohanty D.
    Hemoglobin; 2004 May 15; 28(2):157-61. PubMed ID: 15182059
    [Abstract] [Full Text] [Related]

  • 53. BetaS-haplotypes in sickle cell anemia patients from Salvador, Bahia, Northeastern Brazil.
    Gonçalves MS, Bomfim GC, Maciel E, Cerqueira I, Lyra I, Zanette A, Bomfim G, Adorno EV, Albuquerque AL, Pontes A, Dupuit MF, Fernandes GB, dos Reis MG.
    Braz J Med Biol Res; 2003 Oct 15; 36(10):1283-8. PubMed ID: 14502357
    [Abstract] [Full Text] [Related]

  • 54. Genotypic heterogeneity and correlation to intergenic haplotype within high HbF beta-thalassemia intermedia.
    Papachatzopoulou A, Kourakli A, Makropoulou P, Kakagianne T, Sgourou A, Papadakis M, Athanassiadou A.
    Eur J Haematol; 2006 Apr 15; 76(4):322-30. PubMed ID: 16519704
    [Abstract] [Full Text] [Related]

  • 55. Inhibition of gene expression by the Ggamma 5' flanking region of the Bantu beta(s) chromosome.
    Thomas JJ, Kutlar A, Scott DF, Lanclos KD.
    Am J Hematol; 1998 Sep 15; 59(1):51-6. PubMed ID: 9723577
    [Abstract] [Full Text] [Related]

  • 56. Concordant fetal hemoglobin response to hydroxyurea in siblings with sickle cell disease.
    Steinberg MH, Voskaridou E, Kutlar A, Loukopoulos D, Koshy M, Ballas SK, Castro O, Barton F.
    Am J Hematol; 2003 Feb 15; 72(2):121-6. PubMed ID: 12555216
    [Abstract] [Full Text] [Related]

  • 57. Genotype-phenotype correlation of sickle cell disease in the United Arab Emirates.
    el-Kalla S, Baysal E.
    Pediatr Hematol Oncol; 1998 Feb 15; 15(3):237-42. PubMed ID: 9615321
    [Abstract] [Full Text] [Related]

  • 58. beta S haplotypes, alpha-globin gene status, and hematological data of sickle cell disease patients in Guadeloupe (F.W.I.).
    Kéclard L, Ollendorf V, Berchel C, Loret H, Mérault G.
    Hemoglobin; 1996 Feb 15; 20(1):63-74. PubMed ID: 8745433
    [Abstract] [Full Text] [Related]

  • 59. Combined and differential effects of alpha-thalassemia and HbF-quantitative trait loci in Senegalese hydroxyurea-free children with sickle cell anemia.
    Gueye Tall F, Martin C, Ndour EHM, Renoux C, Ly ID, Connes P, Gueye PM, Diallo RN, Diagne I, Diop PA, Cissé A, Lopez Sall P, Joly P.
    Pediatr Blood Cancer; 2019 Oct 15; 66(10):e27934. PubMed ID: 31322815
    [Abstract] [Full Text] [Related]

  • 60. Sickle-cell disease in Brazzaville, Congo: genetical, hematological, biochemical and clinical aspects.
    Mouélé R, Boukila V, Fourcade V, Feingold J, Galactéros F.
    Acta Haematol; 1999 Oct 15; 101(4):178-84. PubMed ID: 10436298
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.